Origin and Transformation of T Cell Progenitors
- đ¤ Speaker: Professor Hans-Reimer Rodewald, German Cancer Research Center, Heidelberg
- đ Date & Time: Wednesday 30 November 2011, 12:30 - 13:30
- đ Venue: Lecture Theatre, Department of Pathology, Tennis Court Road
Abstract
We mapped the origin of the majority of T cell progenitors in the thymus to an interleukin 7 receptor (Il7r)-expressing progenitor, consistent with a lymphoid-primed route from bone marrow to thymus. Most of these T cell progenitors lacked myeloid potential in vivo, which argues against the recent notion that T cells and myeloid cells in the thymus share a common progenitor.
By contrast, using a T cell-biased Cre-deleter, we found that Notch1-deficient T cell progenitors were blocked in their T cell development, and gave rise to B cells as well as conventional and plasmacytoid dendritic cells in the thymus. A hallmark of T cell progenitors is their lack of self-renewal.
Hence, thymus function is thought to absolutely depend on continuous supply of new progenitors from the bone marrow. We uncovered the ability of the thymus for autonomous, i.e. bone marrow-independent T cell development. Normally, fit progenitors from the bone marrow prevail over exhausted progenitors in the thymus. Progenitor deprivation resulted in persistence of thymocytes, which frequently results in T cell acute lymphoblastic leukemia (T-ALL) arising in the thymus. These T-ALL share cellular and molecular hallmarks of human T-ALL.
These findings suggest that perturbed progenitor turnover can cause genomic instability and cancer.
Series This talk is part of the Immunology in Pathology series.
Included in Lists
- Biology
- Cambridge Immunology
- Cambridge Infectious Disease
- Cambridge Infectious Diseases
- Lecture Theatre, Department of Pathology, Tennis Court Road
- Life Sciences
- Life Sciences
- ME Seminar
- my_list
- other talks
- Pathology Seminars
Note: Ex-directory lists are not shown.
![[Talks.cam]](/static/images/talkslogosmall.gif)

Professor Hans-Reimer Rodewald, German Cancer Research Center, Heidelberg
Wednesday 30 November 2011, 12:30-13:30